 |
인쇄하기
취소
|
Korean companies in race for domestic vaccine market
Green Cross Corporation and Ilyang Pharm plan to expand their presence in the 300 billion-won domestic vaccine market as demand for various vaccines has been on the gradual increase due to emergence of new influenzae.
Green Cross plans to produce 20 million doses of vaccine with 72 billion won in revenue until 2013.
Green Cross officials said the plant in Hwasun will help stabilize the d...
Green Cross plans to produce 20 million doses of vaccine with 72 billion won in revenue until 2013.
Green Cross officials said the plant in Hwasun will help stabilize the d...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.